Search results
East Bay biotech raises $105 million, aims to enter clinical trials with eczema drug - San Francisco...
The Business Journals· 6 days agoAttovia Therapeutics said the funding was led by Goldman Sachs Alternatives and included...
Dupixent set for FDA review in adolescent chronic inflammatory sinus disease
Pharmaceutical Technology via Yahoo Finance· 3 days agoMany patients also have other type 2 inflammatory diseases such as asthma. Dupixent was first...
13 Penny Stocks with Insider Buying in 2024
Insider Monkey via Yahoo Finance· 4 days agoIn this article, we will take a detailed look at the 13 Penny Stocks with Insider Buying in 2024. If you want to skip our detailed analysis and see the...
Doctors Say These Kitchen Staples Speed Healing of a Painful Skin Ulcer
Woman's World via Yahoo News· 1 day ago(Discover how tea tree oil can ease eczema, too.) Oleksandra Yagello/Getty When to see a doctor for...
How Does Incyte Stock’s Decline During The 2022 Inflation Shock Compare With The 2008 Crash?
Forbes· 2 days agoINCY stock was trading at around $76 in early June 2022, just before the Fed started increasing...
Dupixent® (dupilumab) sBLA Accepted for FDA Priority Review for Treatment of Adolescents with...
Benzinga· 4 days agoFood and Drug Administration (FDA) has accepted for Priority Review the supplemental Biologics License Application (sBLA) for Dupixent® (dupilumab) as an add-on maintenance treatment ...
Kids With Skin Diseases Face Stigma, Reduced Quality of Life
Medscape· 4 days agoMost children with chronic skin diseases — such as acne, alopecia, eczema, psoriasis, and vitiligo —...